Bluejay Diagnostics (BJDX) director Chase received 2,500 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Donald R Chase (director at Bluejay Diagnostics Inc., BJDX) reported that they received 2,500 shares on Mar 22, 2022.
- Reporting person
- Chase Donald R
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 22, 2022 | Grant or award (A) | Option to purchase common stockOn 2,500 Common Stock1, 2 | +2,500 | - | - | 113,262 direct |
Holdings before and after
- Option to purchase common stock: 110,762 to 113,262 direct
Footnotes from the filing
- 1. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date.
- 2. The stock options were issued in connection with the reporting person's Board of Director services to the Company.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Chase report in this BJDX Form 4?
Donald R Chase (director at Bluejay Diagnostics Inc., BJDX) reported that they received 2,500 shares on Mar 22, 2022.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for BJDX
Earlier insider filings at BJDX
- Mar 23, 2022SEC Form 4 filed by Zeidman Fred S
- Mar 23, 2022SEC Form 4 filed by Wurth Douglas Clark
- Mar 23, 2022SEC Form 4 filed by Dey Svetlana
- Mar 21, 2022SEC Form 4: Kinder Gordon Winston bought $2,898 worth of shares (2,500 units at $1.16), increasing direct ownership by 16% to 18,500 units
- Mar 21, 2022SEC Form 4: Dey Svetlana bought $11,830 worth of shares (10,000 units at $1.18)
Keep researching BJDX
- BJDX insider tradesEvery buy and sale reported by Bluejay Diagnostics Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- BJDX financial statementsRevenue, profit, cash flow and balance sheet from Bluejay Diagnostics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
BJDX
Bluejay Diagnostics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2021
Get push alerts for BJDX
Full BJDX profile on Quantisnow Follow BJDX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time